Tonix Pharmaceuticals stock halted ahead of FDA approval news
Steven Spoto, PresA&D Integrated Electronics at TTM Technologies INC (NASDAQ:TTMI), sold 3,484 shares of common stock on August 12, 2025, for $46.5823, totaling $162,292.
Following the transaction, Spoto directly owns 28,649 shares of TTM Technologies INC. The sale was executed on the open market. Wall Street remains optimistic about TTM’s prospects, with analyst price targets ranging from $55 to $60. InvestingPro analysis reveals 14 additional key insights about TTM’s valuation and growth prospects, available in the comprehensive Pro Research Report.
In other recent news, TTM Technologies Inc. reported impressive financial results for the second quarter of 2025, exceeding analysts’ expectations. The company achieved an earnings per share (EPS) of $0.58, which surpassed the projected $0.52 by 11.54%. Additionally, TTM Technologies generated $730.6 million in revenue, outperforming the anticipated $668.48 million and reflecting a 21% increase compared to the previous year. These developments highlight the company’s robust performance and its ability to exceed market forecasts. The positive earnings report has drawn attention from various analyst firms. While there were no specific upgrades or downgrades mentioned, the results have likely influenced analysts’ perspectives. Investors may find the revenue and earnings growth noteworthy as they assess the company’s future prospects.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.